Showing results (371-380 of 468) with videos related to

Sort By:
Pageof 47
Heart (British Cardiac Society)|April 7, 2017
Predicting the risk of bleeding during dual antiplatelet therapy after acute coronary syndromesJoakim Alfredsson, Benjamin Neely, Megan L Neely, et al.
The American Journal of Cardiology|February 22, 2005
Comparison of ST-segment resolution with combined fibrinolytic and glycoprotein IIb/IIIa inhibitor therapy versus fibrinolytic alone (data from four clinical trials)Abdallah G Rebeiz, Per Johanson, Cindy L Green, et al.
Circulation. Cardiovascular Quality and Outcomes|February 10, 2011
The impact of postrandomization crossover of therapy in acute coronary syndromes careKenneth W Mahaffey, Karen S Pieper, Yuliya Lokhnygina, et al.
Journal of the American College of Cardiology|February 27, 2016
Impact of CYP2C19 Metabolizer Status on Patients With ACS Treated With Prasugrel Versus ClopidogrelJacob A Doll, Megan L Neely, Matthew T Roe, et al.
JAMA Cardiology|May 30, 2019
P2Y12 Inhibitor Switching in Response to Routine Notification of CYP2C19 Clopidogrel Metabolizer Status Following Acute Coronary SyndromesThomas J Povsic, E Magnus Ohman, Matthew T Roe, et al.
Nucleic Acids Research|December 10, 1998
Using the Saccharomyces Genome Database (SGD) for analysis of protein similarities and structureS A Chervitz, E T Hester, C A Ball, et al.
American Heart Journal|December 18, 2002
Promise of combined low-molecular-weight heparin and platelet glycoprotein IIb/IIIa inhibition: results from Platelet IIb/IIIa Antagonist for the Reduction of Acute coronary syndrome events in a Global Organization Network B (PARAGON B)Debabrata Mukherjee, Kenneth W Mahaffey, David J Moliterno, et al.
Circulation|September 7, 2000
Clinical and therapeutic profile of patients presenting with acute coronary syndromes who do not have significant coronary artery disease.The Platelet Glycoprotein IIb/IIIa in Unstable Angina: Receptor Suppression Using Integrilin Therapy (PURSUIT) Trial InvestigatorsM T Roe, R A Harrington, D M Prosper, et al.
Infection|September 9, 2025
Severe viral infections requiring intensive care unit admissions- aetiology, co-infections, respiratory interventions and outcomesM Brown, F Abeer, T Roe, et al.
Journal of Electrocardiology|November 21, 2017
What is the best ST-segment recovery parameter to predict clinical outcome and myocardial infarct size? Amplitude, speed, and completeness of ST-segment recovery after primary percutaneous coronary intervention for ST-segment elevation myocardial infarctionWichert J Kuijt, Cindy L Green, Niels J W Verouden, et al.
Pageof 47